期刊文献+

轻型帕金森病患者脑多巴胺转运蛋白的SPECT显像

下载PDF
导出
出处 《浙江临床医学》 2008年第1期136-137,共2页 Zhejiang Clinical Medical Journal
基金 由温州市科委课题支持(编号S2002A091及Y2005A020)
  • 相关文献

参考文献8

  • 1Hughes AJ,Daniel SE,Kilford L,et al.Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinical pathological study of 100 cases.J Neurol Neurosurg Psychiatry,1992,55:181.
  • 2Maria2Joao R,Marie V,Christian L,et al.Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinsonps disease.Arch Neurol,2002,59:580.
  • 3王坚,蒋雨平,管一晖,项景德,陈正平,赵军,苏惠琳,杨莉芹,郭丽萍,邬剑军,丁正同.帕金森病患者临床量表UPDRS与^(18)F-FP-CIT PET-DAT功能显像相关性的研究[J].中国临床神经科学,2003,11(4):329-332. 被引量:10
  • 4Fernandez HH,Friedman JH,Fischman AJ,et al.Is altropane SPECT more sensitive to fluoroDOPA PETfor detecting early Parkinson's disease ? Med Sci Monit,2001,7:1339-1343.
  • 5杨健,苏敏,刘秀芊,梁伟娟,赵斌,许志恩.脑多巴胺转运蛋白显像剂^(99)Tc^m-TRODAT-1的SPECT显像[J].中华核医学杂志,2006,26(1):51-53. 被引量:5
  • 6HuangWS,Lee MS,Lin JC,et al.Usefulness of brain99mTc-TRODAT-1 SPECT for the evaluation of Parkinson's disease.Eur J Nucl Med Mol Imaging,2004,31(2):155.
  • 7Tzen KY,Lu CS,Yen TC,et al.Differential diagnosis of Parkinson's disease and vascular parkinsonism by99mTc 2TRODAT21.J Nucl Med,2001,42:408-413.
  • 8Becker G.Methods for the early diagnosis of Parkinson's disease.Nervenarzt,2003,74:7-11.

二级参考文献15

  • 1贾少微,时杰,高宙,陈红艳,翁咏梅,杨苹花.脑多巴胺转运蛋白^(99)Tc^m-TRODAT-1显像研究[J].中华核医学杂志,2003,23(S1):44-47. 被引量:12
  • 2耿昱,史国华,江云,徐凌勋,胡兴越,邵宇权.Investigating the role of^(99m)Tc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2005,6(1):22-27. 被引量:5
  • 3Zouzeilles MI, Merello M. Correlation between results of motor section of UPDRS and Webster Scale[J]. Mov Disotd. 1997,12:613.
  • 4Patrick SK, Denington AA, Gauthier M J, et al. Quantification of the UPDRS Rigidity, Scale. IEEE Trans Neural Syst[J]. Rehabil Eng, 2001,9:31-41.
  • 5Tison F, Yekhief F, Chrysostome V, et al. Parkinsonism in multiple system atrophy: natural history, severity ( UPDRS-Ⅲ), and disability assessment compared with Parkinson's disease[J]. Mov Disord,2002; 17:701-709.
  • 6Brooks DJ. Monitoring neuroprotectian and restorative theraies in Parkinson's disease with PET[J] .J Neural Transtn, 2000(Suppl), 125-137.
  • 7Brucke T, Djamshidian S, Bencsits G, et al. SPECT and PET imaging of the dopaminergic system in Parkinson ' s disease[ J ]. J Neurol, 2000,247 ( Suppl4) :2-7.
  • 8Kazunmta K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-EPCIT mad PET[J] .J Nucl Med, 1998,39:1521-1530.
  • 9Rinne JO, Ruotlinen H, Bergnmn J, el al. Usefulness of a dopamine transporter PET ligand [(18) F] bela-CFT in assessing disability in Parkinson ' s disease[ J ]. J Neurol Neurosurg Psychiatry, 1999,67 : 737-741.
  • 10Nurmi E, Ruottinen HM, Bergman J, et al. Rate of progression in Parkinso's disease:a 6-[ 18F]fluoro-L-dopa PET study[J]. Mov Disord,2001,16:608-815.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部